Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of

Ajit C Dhadve1, Kishore Hari2, Bharat Rekhi3

  • 1Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India; Homi Bhabha National Institute, Anushakti Nagar, Mumbai, India.

Insights

Runt-related transcription factor 1 (RUNX1) and Forkhead Box O3 (FOXO3a) regulate Insulin-like growth factor 1 receptor (IGF1R) expression during ovarian cancer chemoresistance. RUNX1 inhibition reduces tumor growth and enhances drug sensitivity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Hyperactive Insulin-like Growth Factor-1 Receptor (IGF1R) signaling is linked to cancer therapy resistance.
  • Epithelial Ovarian Cancer (EOC) cells exhibit pulsatile IGF1R expression during platinum-taxol resistance acquisition.
  • Therapy can induce IGF1R upregulation in high-grade serous EOC patient tumors.

Purpose of the Study:

  • To identify novel transcriptional regulators of IGF1R during chemoresistance development in EOC.
  • To elucidate the cooperative and dynamic roles of RUNX1 and FOXO3a in modulating IGF1R expression.
  • To investigate the therapeutic potential of targeting the RUNX1-IGF1R axis in chemoresistant EOC.

Main Methods:

  • Investigated the roles of RUNX1 and FOXO3a in regulating IGF1R expression in EOC cells.
  • Analyzed the cooperative binding of RUNX1-FOXO3a to the IGF1R promoter.
  • Examined the influence of a Protein Kinase B (AKT)-FOXO3a negative feedback loop on IGF1R and FOXO3a expression.
  • Utilized in vivo molecular imaging to assess the effects of RUNX1 inhibition on tumor growth and drug sensitivity.

Main Results:

  • RUNX1 and FOXO3a cooperatively bind to the IGF1R promoter, driving an initial surge in IGF1R expression during resistance development.
  • This cooperation diminishes in highly resistant cells, leading to decreased IGF1R expression.
  • A negative feedback loop involving AKT and FOXO3a in resistant cells causes pulsatile IGF1R and FOXO3a expression.
  • RUNX1 inhibition in early resistant cells significantly reduced IGF1R promoter activity, tumorigenicity, and enhanced drug sensitivity.

Conclusions:

  • RUNX1 acts as a novel transcriptional regulator of IGF1R in EOC chemoresistance.
  • A dynamic interplay between RUNX1, FOXO3a, and AKT governs pulsatile IGF1R expression.
  • Targeting the RUNX1-IGF1R axis presents a promising therapeutic strategy for overcoming chemoresistance in EOC.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

3.8K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.5K